Live feed03:04:00·237dPRReleasevia QuantisnowTakeda Reports First Half FY2025 Results, with Business Fundamentals Tracking as Planned. Updates Full Year Outlook to Reflect FX Impact and Pipeline Impairment. On Track for Multiple Regulatory Filings This Fiscal YearByQuantisnow·Wall Street's wire, on your screen.TAK· Takeda Pharmaceutical Company LimitedHealth Care
